Top 10 oligotherapeutics.org Wettbewerber

sutrobio.com

sutro biopharma, inc. is a public biotechnology company headquartered in south san francisco, california focused on clinical stage drug discovery, development and manufacturing company. using its integrated cell-free protein synthesis platform, xpresscf, to create a variety of protein therapeutics for cancer and autoimmune disorders. it focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (i/o) therapeutics, antibody-drug conjugates (adcs) and bispecific antibodies that are directed primarily against clinically validated targets. its product candidates include stro-001 and stro-002. stro-001 is an adc directed against the cancer target cd74, for patients with multiple myeloma and non-hodgkin lymphoma (nhl). stro-002 is an adc directed against folate receptor-alpha (folra), for patients with ovarian and endometrial cancers. stro-001 and stro-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody using its xpresscf platform.

gossamerbio.com

USA Office3115 Merryfield RowSuite 120San Diego, CA 92121 Ireland Office77 Sir John Rogerson’s Quay, Block CGrand Canal DocklandsDublin 2, D02 VK60 Sponsorship DisclosureAnnual Grant & Sponsorship Disclosure Global Reports Grant & Sponsorship Disclosure Global Report 2022 (Download)Grant & Sponsorship Disclosure Global Report 2021 (Download)

celldex.com

Celldex is developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.

molecularpartners.com

Molecular Partners develops DARPin therapeutics for cancer and serious diseases through innovative oncology and radiopharmaceutical programs.

bioprocessingsummit.com

Get instant access to exclusive interviews like Min Zhang, PhD, Director, Manufacturing Sciences and Technology, AstraZeneca. Explore the podcasts and gain insight from top experts.

n1collaborative.org

The N=1 Collaborative is an international network of experts working together to bring individualized treatments to rare disease patients as safely and quickly as possible. We are on a mission to make them safe and rapidly accessible to patients world-wide.

altasciences.com

contract research organization specialized in seamless, end-to-end, early phase drug development, we act to get your most promising compounds into and through early phase clinical trials.

judo.bio

Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.

blog.ambrygen.com

From the moment I was diagnosed with breast cancer I knew there was something bigger out there for me. I've always believed that.

allencell.org

News from the Allen Institute for Cell Science.